Molecular Therapy-methods & Clinical Development

雜志介紹

Molecular Therapy-methods & Clinical Development雜志介紹

《Molecular Therapy-methods & Clinical Development》是一本以English為主的開放獲取國際優秀期刊，中文名稱分子治療方法和臨床開發，本刊主要出版、報道醫學-MEDICINE, RESEARCH & EXPERIMENTAL領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。最新CiteScore 指數為9.9。

本刊近期中國學者發表的論文主要有：

• Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research

  Author: Liting You, Mengqian Li, Ruizhan Tong, Yuncong Liu, Jianxin Xue, You Lu

• Rational Design of Gene Therapy Vectors

  Author: Dao Pan, Hildegard Büning, Chen Ling

• MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7

  Author: Xufeng Luo, Dongmei Zhang, Jun Xie, Qin Su, Xing He, Ruipu Bai, Guangping Gao, Weiqing Pan

• P-FN12, an H4R-Based Epitope Vaccine Screened by Phage Display, Regulates the Th1/Th2 Balance in Rat Allergic Rhinitis

  Author: Yuqian Wang, Jichao Sha, Heng Wang, Lifeng An, Tie Liu, Lin Li

英文介紹

Molecular Therapy-methods & Clinical Development雜志英文介紹

The aim of Molecular Therapy—Methods & Clinical Development is to build upon the success of Molecular Therapy in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella.

Topics of particular interest within the journal's scope include:

Gene vector engineering and production,

Methods for targeted genome editing and engineering,

Methods and technology development for cell reprogramming and directed differentiation of pluripotent cells,

Methods for gene and cell vector delivery,

Development of biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine,

Analysis of gene and cell vector biodistribution and tracking,

Pharmacology/toxicology studies of new and next-generation vectors,

Methods for cell isolation, engineering, culture, expansion, and transplantation,

Cell processing, storage, and banking for therapeutic application,

Preclinical and QC/QA assay development,

Translational and clinical scale-up and Good Manufacturing procedures and process development,

Clinical protocol development,

Computational and bioinformatic methods for analysis, modeling, or visualization of biological data,

Negotiating the regulatory approval process and obtaining such approval for clinical trials.